KLRK1 and neoplasm: In a preclinical study conducted by Leivas et al. [139], NKG2D-CAR-NK cells demonstrated a potent eradication of tumor cells along with remarkable suppression of tumor growth; however, no effective responses were detected using NKG2D CAR-transduced T cells.